Drug-eluting stent outcomes in diabetes

Expert Review of Cardiovascular Therapy
Chiara BernelliAlaide Chieffo

Abstract

Diabetic population still remains a challenging subgroup of patients for percutaneous coronary intervention (PCI). However, with rapid advancements of PCI techniques, devices and adjunctive drug therapy, clinical outcomes for diabetic patients after PCI have markedly improved. The plethora of recent encouraging data with newer generation drug-eluting stent (DES), with a lower frequency of major cardiac adverse events, lead to an increasing use of DES in this particular high-risk population. However, diabetes remains an important risk factor for coronary events, even in the DES era. This review summarizes the outcomes in diabetic patients undergoing PCI with DES implantation.

References

Mar 1, 1996·Journal of the American College of Cardiology·D AronsonE J Rayfield
Sep 19, 1998·Journal of the American College of Cardiology·A AbizaidM B Leon
Aug 5, 2000·European Heart Journal·W Wijns, F Ribichini
Jul 27, 2001·Diabetes Care·A I VinikG L Pittenger
Oct 3, 2003·The New England Journal of Medicine·Jeffrey W MosesUNKNOWN SIRIUS Investigators
Aug 12, 2004·Journal of Thrombosis and Haemostasis : JTH·P FerroniG Davì
Apr 20, 2005·Journal of the American College of Cardiology·James B HermillerUNKNOWN TAXUS-IV Investigators
May 5, 2005·JAMA : the Journal of the American Medical Association·Ioannis IakovouAntonio Colombo
Aug 18, 2005·The New England Journal of Medicine·Alban DibraUNKNOWN ISAR-DIABETES Study Investigators
Nov 25, 2005·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Bernd Stratmann, Diethelm Tschoepe
Jul 25, 2006·The American Journal of Cardiology·Duk-Woo ParkSeung-Jung Park
Feb 14, 2007·The New England Journal of Medicine·Christian SpauldingPatrick W Serruys
Sep 26, 2007·American Heart Journal·Raisuke IijimaAdnan Kastrati
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity·Dominick J Angiolillo
Oct 24, 2007·Journal of the American College of Cardiology·Dietrich BaumgartUNKNOWN SCORPIUS Study Investigators
Feb 19, 2008·Journal of the American College of Cardiology·Ajay J KirtaneGregg W Stone
Mar 18, 2008·Journal of Interventional Cardiology·Moo Hyun KimDo-Sun Lim
Apr 24, 2008·JAMA : the Journal of the American Medical Association·Gregg W StoneUNKNOWN SPIRIT III Investigators
Jul 19, 2008·Journal of the American College of Cardiology·Stephen J NichollsSteven E Nissen
Aug 23, 2008·Journal of the American College of Cardiology·Seung-Whan LeeSeung-Jung Park
Sep 2, 2008·BMJ : British Medical Journal·Christoph StettlerPeter Jüni
Oct 25, 2008·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Charles ChanUNKNOWN DECODE Investigators
May 7, 2010·The New England Journal of Medicine·Gregg W StoneUNKNOWN SPIRIT IV Investigators
Jun 18, 2010·The New England Journal of Medicine·Patrick W SerruysStephan Windecker
Jan 12, 2011·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Antoinette de WahaAdnan Kastrati
Feb 24, 2011·Circulation·José Luis Ferreiro, Dominick J Angiolillo

❮ Previous
Next ❯

Citations

Jun 19, 2014·Expert Review of Cardiovascular Therapy·George KassimisAdrian P Banning
May 5, 2017·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Carlos M CamposUNKNOWN ABSORB Cohort B and the SPIRIT II, III, and IV Investigators.
Sep 20, 2015·Annals of Biomedical Engineering·C M McKittrickC McCormick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.